Secondary outcomes included the risks of specific cancers in the tirzepatide group versus the control groups
Companies are investing heavily in R&D to develop bioavailable, non-irritant formulations that meet regulatory standards, further expanding market opportunities
Synovial fluid metabolome can differentiate between healthy joints and joints affected by osteoarthritis in horses
This enables your healthcare professional to provide appropriate monitoring and support throughout treatment
Two members insured by the same carrier can have different benefits because of employer choices or plan design
If the machinery behind that process is already compromised, dirty genes, underperforming enzymes, insufficient cofactors, an overloaded liver, the backlog gets worse